![Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management - ScienceDirect Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0272638609015649-gr3.jpg)
Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management - ScienceDirect
![American Society of Pediatric Nephrology on Twitter: "Tumor Lysis Syndrome: Allopurinol vs Rasburicase #Nephpearls #IMpearls https://t.co/qyPAkT3lzK https://t.co/bH9aXBS8WS @edgarvlermamd" / Twitter American Society of Pediatric Nephrology on Twitter: "Tumor Lysis Syndrome: Allopurinol vs Rasburicase #Nephpearls #IMpearls https://t.co/qyPAkT3lzK https://t.co/bH9aXBS8WS @edgarvlermamd" / Twitter](https://pbs.twimg.com/media/CbEdLO7XEAAWlBE.jpg)
American Society of Pediatric Nephrology on Twitter: "Tumor Lysis Syndrome: Allopurinol vs Rasburicase #Nephpearls #IMpearls https://t.co/qyPAkT3lzK https://t.co/bH9aXBS8WS @edgarvlermamd" / Twitter
![PPT - Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Children's Hospital November 14, 2011 PowerPoint Presentation - ID:5660602 PPT - Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Children's Hospital November 14, 2011 PowerPoint Presentation - ID:5660602](https://image3.slideserve.com/5660602/slide24-l.jpg)
PPT - Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Children's Hospital November 14, 2011 PowerPoint Presentation - ID:5660602
![Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.leu.2402847/MediaObjects/41375_2003_Article_BF2402847_Fig2_HTML.gif)
Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia
![Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.leu.2402847/MediaObjects/41375_2003_Article_BF2402847_Fig1_HTML.jpg)
Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia
![A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia - ScienceDirect A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0145212621000898-gr1.jpg)
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia - ScienceDirect
Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies - Document - Gale Academic OneFile
![Figure 4 | An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature Review Figure 4 | An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature Review](https://static-02.hindawi.com/articles/crim/volume-2012/468452/figures/468452.fig.004.jpg)